24m
What to Know About This Fund’s New $22 Million Xenon Pharmaceuticals Buy Ahead of an FDA Filing
Xenon Pharmaceuticals develops therapies for neurological disorders, with a pipeline targeting epilepsy and related ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results